Botulinum toxin injection for the treatment of oromandibular dystonia
- PMID: 2916831
- DOI: 10.1177/000348948909800202
Botulinum toxin injection for the treatment of oromandibular dystonia
Abstract
Dystonia is a neurologic disorder characterized by abnormal, involuntary movements causing twisting and turning postures; it is postulated to be a disorder of central motor processing. The dystonias, when classified by region of the body involved, have been characterized as focal, segmental, and generalized. Focal dystonia can affect jaw mechanics, leading to forceful contraction of the jaw muscles and resulting in inappropriate deviation of the jaw. Localized injections of botulinum toxin have been used successfully in the management of other focal or segmental dystonias. We have treated 20 oromandibular dystonia patients with botulinum toxin. Six patients had only jaw and tongue involvement; 11 had blepharospasm and jaw involvement; and three had jaw involvement as part of a more generalized dystonia. Five patients had been diagnosed originally and treated as having temporomandibular joint syndrome. All but one of the patients had improvement of their symptoms with the toxin injections. The patients averaged 47% improvement with the injections.
Similar articles
-
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.Mov Disord. 1987;2(4):237-54. doi: 10.1002/mds.870020402. Mov Disord. 1987. PMID: 3504553
-
Oromandibular dystonia: long-term management with botulinum toxin.Laryngoscope. 2013 Dec;123(12):3078-83. doi: 10.1002/lary.23265. Epub 2013 Oct 5. Laryngoscope. 2013. PMID: 24122897
-
[Clinical aspects and therapy of dystonias].Fortschr Neurol Psychiatr. 1995 Mar;63(3):99-105. doi: 10.1055/s-2007-996608. Fortschr Neurol Psychiatr. 1995. PMID: 7759050 Review. German.
-
The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.Int J Neurosci. 2011;121 Suppl 1:44-56. doi: 10.3109/00207454.2011.558260. Int J Neurosci. 2011. PMID: 21348790 Clinical Trial.
-
[Treatment of movement disorders using botulinum toxin].Schweiz Med Wochenschr. 1992 Sep 5;122(36):1311-6. Schweiz Med Wochenschr. 1992. PMID: 1411387 Review. German.
Cited by
-
The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review.J Dent (Shiraz). 2017 Sep;18(3):157-164. J Dent (Shiraz). 2017. PMID: 29034269 Free PMC article. Review.
-
S100 and p65 expression are increased in the masseter muscle after botulinum toxin-A injection.Maxillofac Plast Reconstr Surg. 2016 Aug 26;38(1):33. doi: 10.1186/s40902-016-0079-8. eCollection 2016 Dec. Maxillofac Plast Reconstr Surg. 2016. PMID: 27635391 Free PMC article.
-
Botulinum toxin in the treatment of muscle specific Oro-facial pain: a literature review.J Maxillofac Oral Surg. 2015 Jun;14(2):171-5. doi: 10.1007/s12663-014-0641-9. Epub 2014 Sep 4. J Maxillofac Oral Surg. 2015. PMID: 26028831 Free PMC article. Review.
-
Botulinum toxin therapy.West J Med. 1991 Jul;155(1):69-70. West J Med. 1991. PMID: 1877240 Free PMC article. No abstract available.
-
Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.J Neural Transm (Vienna). 2019 Feb;126(2):141-148. doi: 10.1007/s00702-018-1960-7. Epub 2019 Jan 2. J Neural Transm (Vienna). 2019. PMID: 30604200
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical